Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Angel D who wrote (1384)	10/4/1999 8:25:00 AM
From: CMon	Respond to of 1432

<<"I was baited to make the appearance...". Kind of how you tried to bait me so that you could "jab" me, eh?>> Yes, exactly. I was looking forward to poking at any fool who'd venture the opinion that a move to the amex would change the picture. <<At least, you admit that you are a "short". I.E. "Now we all wait for one thing: sales data." The "we" thing kind of gives you away, doesn't it?>> A bit paranoid are "we"? By "we" I meant all those with an interest in the following the compayy. Nevertheless, I do think this stock is a great short. <<The product HAS been approved by the FDA and is now being sold.>> So? It was never the shorts' thesis that this product wouldn't be approved. Approval hastens the day when we'll see how well the product is received and, if the shorts are correct, the end of the story. <<There are more products in the pipeline, which will probably get expedited FDA approval.>> Oh I see. Wait a minute. The debate has focused on Hextend and its miracle potential for years, but in case that disappoints...